Literature DB >> 14735448

Tanshinone IIA from Salvia miltiorrhiza inhibits inducible nitric oxide synthase expression and production of TNF-alpha, IL-1beta and IL-6 in activated RAW 264.7 cells.

Seon-Il Jang1, Seung-Il Jeong, Kang-Ju Kim, Hyung-Jin Kim, Hyeon-Hee Yu, Raekil Park, Hyung-Min Kim, Yong-Ouk You.   

Abstract

The inhibitory effects of tanshinone IIA, a diterpene isolated from Salvia miltiorrhiza root, on the production of nitric oxide (NO), interleukin-1beta (IL-1beta), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), and the expression of inducible nitric oxide synthase (iNOS) were investigated in activated RAW 264.7 cells. This compound markedly inhibited the production of NO, IL-1beta and TNF-alpha, and suppressed the expression of iNOS in a dose-dependent manner. These results suggest that the traditional use of S. miltiorrhiza as an anti-inflammatory herbal medicine may be explained, in part, by the inhibition of NO, IL-1beta, IL-6 and TNF-alpha production, and expression of iNOS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14735448     DOI: 10.1055/s-2003-45157

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  34 in total

1.  Effect of salvia miltiorrhizae on the expressions of TLR4 protein in the liver of rats with SAP or OJ.

Authors:  Xiping Zhang; Daren Liu; Dijiong Wu; Chongmei Zhu; Jing Ye; Keyi Wang; Liang Peng; Guangchao Zhuo
Journal:  Inflammation       Date:  2009-06       Impact factor: 4.092

2.  Up-regulation of PYK2/PKCα-dependent haem oxygenase-1 by CO-releasing molecule-2 attenuates TNF-α-induced lung inflammation.

Authors:  Chih-Chung Lin; Yu-Ching Chiang; Rou-Ling Cho; Wei-Ning Lin; Chien-Chung Yang; Li-Der Hsiao; Chuen-Mao Yang
Journal:  Br J Pharmacol       Date:  2017-12-22       Impact factor: 8.739

3.  A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1.

Authors:  Wei Li; Jianhua Li; Mala Ashok; Rongqian Wu; Dazhi Chen; Lihong Yang; Huan Yang; Kevin J Tracey; Ping Wang; Andrew E Sama; Haichao Wang
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

4.  Tanshinone IIA therapeutically reduces LPS-induced acute lung injury by inhibiting inflammation and apoptosis in mice.

Authors:  Min Xu; Fa-le Cao; Yu-fei Zhang; Liang Shan; Xiao-ling Jiang; Xiao-jing An; Wei Xu; Xiu-zhi Liu; Xiao-yan Wang
Journal:  Acta Pharmacol Sin       Date:  2014-12-29       Impact factor: 6.150

5.  Tanshinone IIA Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice Infected with Porphyromonas gingivalis.

Authors:  Yan Xuan; Yue Gao; Hao Huang; Xiaoxuan Wang; Yu Cai; Qing Xian Luan
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

Review 6.  Inflammatory response and immune regulation of high mobility group box-1 protein in treatment of sepsis.

Authors:  Qing-Yang Liu; Yong-Ming Yao
Journal:  World J Emerg Med       Date:  2010

Review 7.  Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.

Authors:  Zhuo-Ming Li; Suo-Wen Xu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

8.  Tanshinone IIA: A Promising Natural Cardioprotective Agent.

Authors:  Qinghua Shang; Hao Xu; Li Huang
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-06       Impact factor: 2.629

Review 9.  Tanshinones: sources, pharmacokinetics and anti-cancer activities.

Authors:  Yong Zhang; Peixin Jiang; Min Ye; Sung-Hoon Kim; Cheng Jiang; Junxuan Lü
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

10.  Cardiovascular effects of salvianolic Acid B.

Authors:  Jie Wang; Xingjiang Xiong; Bo Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-10       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.